Working… Menu

Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02212886
Recruitment Status : Active, not recruiting
First Posted : August 8, 2014
Last Update Posted : August 16, 2021
Information provided by (Responsible Party):
Mapi Pharma Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 2017
Estimated Study Completion Date : November 2024